NCT06579625

Brief Summary

Participants will be randomly assigned to the experimental and control groups. The study will involve a total of 78 participants, with 39 in the experimental group and 39 in the control group. The 39 participants assigned to the experimental group will first complete the cancer knowledge burden, and attitudes and information about cancer screenings scales. They will then receive cancer education consisting of four modules, which will be completed over four weeks. At the end of these four weeks, they will complete the scales again. One month after the education, the experimental group will complete the scales once more for follow-up monitoring. The control group will first complete the cancer knowledge burden, and attitudes and information about cancer screenings scales after agreeing to participate in the study. They will complete the scales again one month later. The evaluation of the education in the experimental group will involve comparing the scales completed before and after the education.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
79

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 30, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

September 10, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2024

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2024

Completed
Last Updated

September 3, 2024

Status Verified

August 1, 2024

Enrollment Period

1 month

First QC Date

August 29, 2024

Last Update Submit

August 29, 2024

Conditions

Keywords

CancerCancer ScreeningCaregiverHealth Belief ModelInformationAttitudeHealth Education

Outcome Measures

Primary Outcomes (1)

  • İnformation Towards Cancer Screening Scale

    The scale consists of 15 items and is unidimensional. It is a five-point Likert scale. The items on the scale are answered on a range from 1 to 5 as follows: \"5: Strongly agree, 4: Agree, 3: Neither agree nor disagree, 2: Disagree, 1: Strongly disagree.\" The scale is suitable for use with men and women aged 30-70 who are at least literate and do not have cognitive, visual, or orthopedic disabilities that would prevent them from answering the scale. The administration method of the scale should be such that the researcher observes the participant, and the participant reads and answers the scale items independently. The scale can be used in any situation where it is necessary to measure attitudes towards cancer screenings, provided that the appropriate sample and administration method are used. The lowest possible score on the scale is 15 and the highest is 75. There is no specific cutoff point for the scale. Scores close to 15 indicate

    one month

Secondary Outcomes (2)

  • Cancer Knowledge Burden

    one month

  • Attitudes Towards Cancer Screening Scale

    one mounth

Study Arms (2)

experimental group

OTHER

The effect of cancer education on cancer knowledge burden, information about cancer screenings, and attitudes will be evaluated by providing cancer education to 39 patients in the experimental group.

Other: Cancer education

Control group

NO INTERVENTION

The control group will not receive any intervention.

Interventions

Participants in the experimental group will receive cancer education.

experimental group

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals who agree to participate in the study, are aged 30-70,
  • Are literate,
  • Do not have any auditory, visual, cognitive, or orthopedic disabilities that would prevent participation,
  • Are not receiving palliative care services, will be included. This includes caregivers of cancer patients.

You may not qualify if:

  • Individuals under the age of 30 or over the age of 70,
  • Those who are illiterate,
  • Those with disabilities that would prevent participation in the study,
  • Those who provide care for cancer patients receiving palliative care services will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Abdurrhman Yurtaslan Oncology Education and Research Hospital

Ankara, 06200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

NeoplasmsBehaviorHealth Education

Condition Hierarchy (Ancestors)

Adherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: two group with a of Health Belief Model-Based cancer education control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
nurse

Study Record Dates

First Submitted

August 29, 2024

First Posted

August 30, 2024

Study Start

September 10, 2024

Primary Completion

October 10, 2024

Study Completion

October 28, 2024

Last Updated

September 3, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations